Is RPG Life Sciences the Best Stock in Its Sector? A Look at the Numbers
- October 7, 2026
- Posted by: Ankit Jaiswal
- Category: Market
RPG Life Sciences CMP Rs 2,933 (6 Oct 2026 close). Market cap Rs 4,858 Cr. ROE 19.03%. P/E 40.60x versus Industry P/E 37.19x.
Quick Answer
RPG Life Sciences is one of the names investors compare when screening the Healthcare sector, built on a 19.03% return on equity and a P/E of 40.60x against an Industry P/E of 37.19x. Whether RPG Life Sciences is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is RPG Life Sciences the best stock in its sector? The stock trades on the NSE at Rs 2,933 as of 07 October 2026, within its 52-week range of Rs 1,733.00 to Rs 3,127.80. RPG Life Sciences Ltd, part of the RPG Group, makes branded pharmaceutical formulations and active ingredients.
RPG Life Sciences sits in the Healthcare sector, and its 19.03% ROE and 40.60x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About RPG Life Sciences
RPG Life Sciences Ltd, part of the RPG Group, makes branded pharmaceutical formulations and active ingredients. Prices are the 6 Oct 2026 close, as the market had not yet opened when this data was taken. The stock is trading close to its 52-week high after rising about 69 percent from its 52-week low, and it trades at a high absolute share price. At a market capitalisation of Rs 4,858 Cr, it is tracked as part of the Healthcare sector on Univest.
Is RPG Life Sciences the Best Stock in Its Sector?
RPG Life Sciences makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 19.03% ROE with a 40.60x P/E against the sector’s 37.19x Industry P/E. RPG Life Sciences’ 40.60x P/E is slightly above the 37.19x Industry P/E, a premium built on a strong 19.03% ROE, though an 8.02x price to book near the 52-week high leaves little room for disappointment.
| Metric | RPG Life Sciences |
|---|---|
| CMP (NSE) | Rs 2,933.20 |
| 52-Week High / Low | Rs 3,127.80 / Rs 1,733.00 |
| Market Cap | Rs 4,858 Cr |
| P/E (TTM) vs Industry P/E | 40.60x vs 37.19x |
| P/B | 8.02 |
| ROE | 19.03% |
| EPS (TTM) | Rs 72.34 |
| Dividend Yield | 0.82% |
| Debt to Equity | 0.03 |
Compare RPG Life Sciences Against Other Healthcare Sector Stocks
How RPG Life Sciences Compares Against Its Healthcare Sector Peers
The table below sets RPG Life Sciences against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| RPG Life Sciences | 4,858 | 40.60 | 19.03% | 0.03 |
| Pfizer | 17,636 | 23.99 | 17.19% | 0.02 |
| Neuland Laboratories | 27,580 | 55.41 | 19.42% | 0.16 |
| Peer average (2 companies) | – | 39.70 | 18.30% | 0.09 |
Against this peer set, RPG Life Sciences’s 19.03% ROE is above the 18.30% peer average, and its P/E of 40.60x runs above the peer average of 39.70x. RPG Life Sciences’ 40.60x P/E is slightly above the 37.19x Industry P/E, a premium built on a strong 19.03% ROE, though an 8.02x price to book near the 52-week high leaves little room for disappointment.
What Makes RPG Life Sciences Worth Watching in Healthcare
- Strong ROE, near debt free: A 19.03% ROE alongside a debt to equity ratio of 0.03 reflects an efficient, well-capitalised business.
- Branded formulations focus: Selling branded pharmaceutical formulations in India gives RPG Life Sciences a more resilient revenue base than commodity drug makers.
- Rich valuation near the high: A 40.60x P/E against a 37.19x Industry P/E, alongside an 8.02x price to book, is demanding with the stock close to its 52-week high.
RPG Life Sciences Valuation: Is It Justified?
RPG Life Sciences’ 40.60x P/E is slightly above the 37.19x Industry P/E, a premium built on a strong 19.03% ROE, though an 8.02x price to book near the 52-week high leaves little room for disappointment. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Refex Industries the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track RPG Life Sciences and other Healthcare sector stocks.
How to Track RPG Life Sciences Before You Invest
Before deciding whether RPG Life Sciences deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for RPG Life Sciences to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
RPG Life Sciences earns a place in the best stock in its sector conversation on the strength of a 19.03% ROE and a P/E of 40.60x against a 37.19x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is RPG Life Sciences the best stock in its sector?
Ans. RPG Life Sciences has a 19.03% ROE and trades at 40.60x P/E against a 37.19x Industry P/E, and compares above the peer average ROE of 18.30% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of RPG Life Sciences?
Ans. RPG Life Sciences was trading at Rs 2,933.20 on the NSE as of 07 October 2026, within its 52-week range of Rs 1,733.00 to Rs 3,127.80.
What sector does RPG Life Sciences belong to?
Ans. RPG Life Sciences is classified under the Healthcare sector on Univest.
How does RPG Life Sciences compare to its sector peers on P/E?
Ans. RPG Life Sciences’s P/E of 40.60x is above the 39.70x average of the 2 named peers compared in this article.
What is RPG Life Sciences’s return on equity?
Ans. RPG Life Sciences reported a return on equity of 19.03%, which is above the 18.30% average of its named peers in this comparison.
Should I invest in RPG Life Sciences based on its sector position?
Ans. RPG Life Sciences’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “Is RPG Life Sciences the best stock in its sector?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “RPG Life Sciences has a 19.03% ROE and trades at 40.60x P/E against a 37.19x Industry P/E, and compares above the peer average ROE of 18.30% in this article’s named comparison, so the answer depends on what an investor is prioritising.”}}, {“@type”: “Question”, “name”: “What is the current share price of RPG Life Sciences?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “RPG Life Sciences was trading at Rs 2,933.20 on the NSE as of 07 October 2026, within its 52-week range of Rs 1,733.00 to Rs 3,127.80.”}}, {“@type”: “Question”, “name”: “What sector does RPG Life Sciences belong to?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “RPG Life Sciences is classified under the Healthcare sector on Univest.”}}, {“@type”: “Question”, “name”: “How does RPG Life Sciences compare to its sector peers on P/E?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “RPG Life Sciences’s P/E of 40.60x is above the 39.70x average of the 2 named peers compared in this article.”}}, {“@type”: “Question”, “name”: “What is RPG Life Sciences’s return on equity?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “RPG Life Sciences reported a return on equity of 19.03%, which is above the 18.30% average of its named peers in this comparison.”}}, {“@type”: “Question”, “name”: “Should I invest in RPG Life Sciences based on its sector position?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “RPG Life Sciences’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.”}}]}
